The protein interaction surfaces between PTK7 and β-catenin thus offer opportunities for new therapeutic strategies to inhibit CRC cell growth dependent on WNT signaling pathway (Fig. 7A) [35]. Here, PTK7 is linked to colorectal carcinoma.